43589

Liver Involvement in Systemic Lupus Erythematosus Patients

Article

Last updated: 04 Jan 2025

Subjects

-

Tags

-

Abstract

Background: Systemic lupus erythematosus (SLE) is a potentially severe, frequently disabling autoimmune disease with multi-organ involvement. Liver involvement in SLE is not uncommon. It is frequently asymptomatic and limited to liver tests abnormalities. Aim: To detect the frequency and nature of liver involvement in SLE patients and to correlate these with other organ involvement. Patients and Methods:A retrospective study included 200 SLE patients who had admitted at Rheumatology and Rehabilitation department, Faculty of Medicine, Cairo university. Patientswere classified into two groups Group I (no liver affection) and Group II (with liver affection). These groups weresubdivided into subgroups; A (6 patients with AIH), B(194 patients without AIH), C(13 patients with fatty changes), D ( 187 patients without fatty changes), E ( 6 patients with HCV) & F (194 patients without HCV).Patients were subjected to full history taking, clinical examination and laboratory investigations; the erythrocyte sedimentation rate (ESR), complete blood count (CBC), serum creatinine, alanine transaminases (ALT), aspartate transaminases (AST), Autoantibodies (ANA and Anti DNA,and AntiLKM), serum complement levels (C3, C4), urine analysis, total albumin in 24 hours urine and HCV by PCR. Liver and renal biopsies were done in selected patients. Patients were also subjected to plain X-ray and abdominal sonography. Assessment of disease damage was measured by using systemic lupus erythematosus international collaborating clinic (SLICC). Results:Liver involvement was found in 23 SLE patients (11%). We classified the 23 patients into 5 major groups: Autoimmune hepatitis in 6 patients (26%), Cholangitis in 1 patient (4.3%), portal venous thrombosis in 2 patients (8.6%), Cirrhosis in 1 patient (4.3%), Liver congestion in 1 patient (4.3%), fatty changes in 13 patients (56.6%), HCV in 6 patients (26%). A significant relation between the age of onset, presence of ascitesand SLICC in group A compared to B (p=0.034, p=0.007and p=0.010respectively)was found. Conclusion: Liverin SLE is the least organ affected. The younger the age group of lupus patients with AIH, the more the organ damage

DOI

10.21608/scumj.2017.43589

Keywords

AIH, nodular regenerative hyperplasia, Antiphospholipid syndrome

Authors

First Name

Amira

Last Name

Shahin

MiddleName

A

Affiliation

Department of Rheumatology & Rehabilitation, Faculty of Medicine, Cairo university, Egypt

Email

-

City

-

Orcid

-

First Name

Ghada

Last Name

Alazkalany

MiddleName

S

Affiliation

Department of Rheumatology & Rehabilitation, Faculty of Medicine, Cairo university, Egypt

Email

-

City

-

Orcid

-

First Name

Maha

Last Name

Hasaballah

MiddleName

S

Affiliation

Department of Rheumatology & Rehabilitation, Faculty of Medicine, Cairo university, Egypt

Email

-

City

-

Orcid

-

First Name

Al Shaymaa

Last Name

Ewiela

MiddleName

A

Affiliation

-

Email

shaima.ewila@yahoo.com

City

-

Orcid

-

Volume

20

Article Issue

2

Related Issue

6812

Issue Date

2017-10-01

Receive Date

2019-08-03

Publish Date

2017-10-01

Page Start

161

Page End

167

Print ISSN

1110-6999

Online ISSN

2090-2581

Link

https://scumj.journals.ekb.eg/article_43589.html

Detail API

https://scumj.journals.ekb.eg/service?article_code=43589

Order

5

Type

Original Article

Type Code

938

Publication Type

Journal

Publication Title

Suez Canal University Medical Journal

Publication Link

https://scumj.journals.ekb.eg/

MainTitle

Liver Involvement in Systemic Lupus Erythematosus Patients

Details

Type

Article

Created At

22 Jan 2023